Healthcare - Biotechnology - NASDAQ - US
$ 1.99
-4.78 %
$ 180 M
Market Cap
-1.2
P/E
Price Target
Average
50.75%
Revenue Forecast
Estimate
76.02%
EBIT
Estimate
--29.95%
Net Income
Estimate
4.30%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Caribou Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for CRBU of $3 , with forecasts ranging from a low of $3 to a high of $3 .
CRBU Lowest Price Target
Wall Street Target
3 USD
50.75%
CRBU Average Price Target
Wall Street Target
3 USD
50.75%
CRBU Highest Price Target
Wall Street Target
3 USD
50.75%
REVENUE FORECAST
Revenue Forecast Chart CRBU
EBIT FORECAST
EBIT Forecast Chart CRBU
NET INCOME FORECAST
Net Income Chart CRBU